tradingkey.logo

tradingkey.logo
怜玢


Charles River Laboratories International Inc

CRL
りォッチリストに远加
150.850USD
-8.250-5.18%
終倀 05/15, 16:00ET15分遅れの株䟡
7.27B時䟡総額
損倱額盎近12ヶ月PER


詳现情報 Charles River Laboratories International Inc 䌁業名

Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.

Charles River Laboratories International Incの䌁業情報


䌁業コヌドCRL
䌚瀟名Charles River Laboratories International Inc
䞊堎日Jun 23, 2000
最高経営責任者「CEO」Foster (James C)
埓業員数18600
蚌刞皮類Ordinary Share
決算期末Jun 23
本瀟所圚地251 Ballardvale St
郜垂WILMINGTON
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜United States of America
郵䟿番号01887
電話番号17812226000
りェブサむトhttps://www.criver.com/
䌁業コヌドCRL
䞊堎日Jun 23, 2000
最高経営責任者「CEO」Foster (James C)

Charles River Laboratories International Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. James C. Foster
Mr. James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
276.94K
+0.67%
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
54.42K
-17.91%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
16.96K
-27.32%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment Management
Corporate Executive Vice President - Discovery and Safety Assessment Management
16.05K
+19.74%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
10.87K
-45.20%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
6.35K
+22.65%
Dr. Nancy C. Andrews, M.D., Ph.D.
Dr. Nancy C. Andrews, M.D., Ph.D.
Independent Director
Independent Director
5.40K
+26.62%
Ms. Reshema Kemps-Polanco
Ms. Reshema Kemps-Polanco
Independent Director
Independent Director
4.56K
+43.24%
Dr. Craig B. Thompson, M.D.
Dr. Craig B. Thompson, M.D.
Independent Director
Independent Director
2.41K
--
Mr. Abraham N. (Abe) Ceesay
Mr. Abraham N. (Abe) Ceesay
Independent Director
Independent Director
2.38K
+60.32%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. James C. Foster
Mr. James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
276.94K
+0.67%
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
54.42K
-17.91%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
16.96K
-27.32%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment Management
Corporate Executive Vice President - Discovery and Safety Assessment Management
16.05K
+19.74%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
10.87K
-45.20%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
6.35K
+22.65%

収益内蚳

通貚: USD曎新時刻: Mon, Apr 6
通貚: USD曎新時刻: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
事業別USD
䌚瀟名
収益
比率
DSA
2.40B
59.84%
RMS
846.08M
21.07%
Manufacturing
766.41M
19.09%
地域別USD
䌚瀟名
収益
比率
United States
2.14B
53.34%
Europe
1.10B
27.46%
Canada
501.02M
12.48%
Asia Pacific (Region)
205.02M
5.11%
Other
64.86M
1.62%
事業別
地域別
事業別USD
䌚瀟名
収益
比率
DSA
2.40B
59.84%
RMS
846.08M
21.07%
Manufacturing
766.41M
19.09%

株䞻

曎新時刻: Thu, May 14
曎新時刻: Thu, May 14
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Vanguard Capital Management, LLC
6.65%
BlackRock Institutional Trust Company, N.A.
5.97%
Vanguard Portfolio Management, LLC
4.76%
Allspring Global Investments, LLC
4.14%
State Street Investment Management (US)
3.89%
他の
74.59%
株䞻統蚈
株䞻統蚈
比率
Vanguard Capital Management, LLC
6.65%
BlackRock Institutional Trust Company, N.A.
5.97%
Vanguard Portfolio Management, LLC
4.76%
Allspring Global Investments, LLC
4.14%
State Street Investment Management (US)
3.89%
他の
74.59%
皮類
株䞻統蚈
比率
Investment Advisor
50.79%
Investment Advisor/Hedge Fund
50.41%
Hedge Fund
9.44%
Research Firm
2.78%
Pension Fund
1.52%
Sovereign Wealth Fund
1.01%
Individual Investor
0.95%
Bank and Trust
0.75%
Family Office
0.09%

機関投資家保有株


曎新時刻: Sun, Apr 5
曎新時刻: Sun, Apr 5
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
1429
56.13M
116.51%
-7.96M
2025Q4
1367
52.25M
129.09%
+28.56K
2025Q3
1413
52.22M
129.54%
+64.86K
2025Q2
1411
52.12M
127.74%
-2.86M
2025Q1
1414
54.69M
123.53%
-5.98M
2024Q4
1410
54.25M
114.75%
+1.17M
2024Q3
1372
53.38M
114.53%
-33.66K
2024Q2
1378
53.46M
111.45%
+347.48K
2024Q1
1371
53.18M
111.09%
-4.05M
2023Q4
1405
52.96M
112.24%
-202.82K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
BlackRock Institutional Trust Company, N.A.
2.88M
5.85%
+56.48K
+2.00%
Dec 31, 2025
Allspring Global Investments, LLC
2.00M
4.05%
-182.34K
-8.37%
Dec 31, 2025
State Street Investment Management (US)
1.87M
3.8%
+40.53K
+2.21%
Dec 31, 2025
Invesco Advisers, Inc.
1.78M
3.61%
+1.63M
+1113.97%
Dec 31, 2025
Wellington Management Company, LLP
1.75M
3.55%
-1.44M
-45.17%
Dec 31, 2025
Harris Associates L.P.
1.68M
3.41%
+204.52K
+13.88%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
1.44M
2.93%
+311.32K
+27.53%
Dec 31, 2025
Fidelity Management & Research Company LLC
1.55M
3.15%
+1.15M
+293.11%
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
Invesco S&P 500 Equal Weight Health Care ETF
1.92%
Schwab Ariel Opportunities ETF
1.82%
iShares Health Innovation Active ETF
1.74%
First Trust NASDAQ Pharmaceuticals ETF
1.71%
ROBO Global Healthcare Technology & Innovation ETF
1.69%
VanEck Biotech ETF
1.44%
Franklin Genomic Advancements ETF
1.42%
WisdomTree US Value Fund
1.15%
Invesco S&P 500 High Beta ETF
1.14%
Pacer Lunt Large Cap Alternator ETF
0.97%
詳现を芋る
Invesco S&P 500 Equal Weight Health Care ETF
比率1.92%
Schwab Ariel Opportunities ETF
比率1.82%
iShares Health Innovation Active ETF
比率1.74%
First Trust NASDAQ Pharmaceuticals ETF
比率1.71%
ROBO Global Healthcare Technology & Innovation ETF
比率1.69%
VanEck Biotech ETF
比率1.44%
Franklin Genomic Advancements ETF
比率1.42%
WisdomTree US Value Fund
比率1.15%
Invesco S&P 500 High Beta ETF
比率1.14%
Pacer Lunt Large Cap Alternator ETF
比率0.97%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™